GLP1R and diabetes mellitus: Furthermore, GLP-1 RAs were associated with a 22% reduction in the incidence of coronary revascularization (RR 0.78; 95% CI: 0.69 to 0.87) compared with placebo in overweight/obese patients without diabetes [76].